Google DeepMind launched AlphaGenome, an AI tool that analyses up to one million DNA letters to predict how mutations disrupt gene regulation and cause disease. Trained on human and mouse genetic data, AlphaGenome helps identify mutations linked to cancer, heart disease, and autoimmune disorders. Researchers say it could accelerate drug discovery and gene therapies by revealing how genes switch on and off in specific cells. Scientists from University College London and the University of Exeter called it a major step toward understanding the genome’s non-coding regions.
DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.